Design, modification, and bio-evaluation of salazinic acid derivatives
Data on synthesized derivatives of salazinic acid are scarce, with existing reports addressing only derivative hexaacetyl salazinic acid. This study investigated a set of novel potential antidiabetic agents. Analogs of salazinic acid were designed and synthesized using bromination, nucleophilic addi...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb74b27e54f54a419bbf36b29bbda4e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fb74b27e54f54a419bbf36b29bbda4e8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fb74b27e54f54a419bbf36b29bbda4e82021-11-26T04:26:07ZDesign, modification, and bio-evaluation of salazinic acid derivatives1878-535210.1016/j.arabjc.2021.103535https://doaj.org/article/fb74b27e54f54a419bbf36b29bbda4e82022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1878535221005505https://doaj.org/toc/1878-5352Data on synthesized derivatives of salazinic acid are scarce, with existing reports addressing only derivative hexaacetyl salazinic acid. This study investigated a set of novel potential antidiabetic agents. Analogs of salazinic acid were designed and synthesized using bromination, nucleophilic addition, Friedel-Crafts alkylation, and esterification. Ten synthetic compounds were prepared and structurally elucidated, including eight new compounds (1a-1c, 2a, 3a, 3b, 4a, 4b) and two known analogs. Under bromination, salazinic acid (1) enabled the following reaction chain: oxidation, decarboxylation, and substitution. This yielded products 1a-1c, which were found to have unprecedented scaffolds. Parmosidone F (5) was prepared from 1 with orsellinic acid via Friedel-Crafts alkylation, confirming a previously reported biosynthesis route. These analogs were evaluated for enzyme inhibition of α-glucosidase, and all showed more potent activity than that of acarbose, a positive control (IC50 332 μM), with IC50 values in the range 9.32–39.96 μM. An in silico molecular docking model confirmed that, in terms of enzyme inhibition, the compounds ranked as follows: 3b > 4b > 4a > 1c > 2a > 1b > 1a > 3a. The kinetics of enzyme inhibition showed 4a and 5 to be a non-competitive-type and mixed-type inhibitors, respectively.Nguyen-Kim-Tuyen PhamNguyen-Minh-An TranHuy Truong NguyenDuc-Dung PhamThi-Quynh-Trang NguyenThi-Hong-Anh NguyenHuu-Tri NguyenThanh-Hung DoNgoc-Hong NguyenThuc-Huy DuongElsevierarticleLichenBrominationNucleophilic additionα-glucosidase inhibitionMolecular dockingKineticChemistryQD1-999ENArabian Journal of Chemistry, Vol 15, Iss 1, Pp 103535- (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Lichen Bromination Nucleophilic addition α-glucosidase inhibition Molecular docking Kinetic Chemistry QD1-999 |
spellingShingle |
Lichen Bromination Nucleophilic addition α-glucosidase inhibition Molecular docking Kinetic Chemistry QD1-999 Nguyen-Kim-Tuyen Pham Nguyen-Minh-An Tran Huy Truong Nguyen Duc-Dung Pham Thi-Quynh-Trang Nguyen Thi-Hong-Anh Nguyen Huu-Tri Nguyen Thanh-Hung Do Ngoc-Hong Nguyen Thuc-Huy Duong Design, modification, and bio-evaluation of salazinic acid derivatives |
description |
Data on synthesized derivatives of salazinic acid are scarce, with existing reports addressing only derivative hexaacetyl salazinic acid. This study investigated a set of novel potential antidiabetic agents. Analogs of salazinic acid were designed and synthesized using bromination, nucleophilic addition, Friedel-Crafts alkylation, and esterification. Ten synthetic compounds were prepared and structurally elucidated, including eight new compounds (1a-1c, 2a, 3a, 3b, 4a, 4b) and two known analogs. Under bromination, salazinic acid (1) enabled the following reaction chain: oxidation, decarboxylation, and substitution. This yielded products 1a-1c, which were found to have unprecedented scaffolds. Parmosidone F (5) was prepared from 1 with orsellinic acid via Friedel-Crafts alkylation, confirming a previously reported biosynthesis route. These analogs were evaluated for enzyme inhibition of α-glucosidase, and all showed more potent activity than that of acarbose, a positive control (IC50 332 μM), with IC50 values in the range 9.32–39.96 μM. An in silico molecular docking model confirmed that, in terms of enzyme inhibition, the compounds ranked as follows: 3b > 4b > 4a > 1c > 2a > 1b > 1a > 3a. The kinetics of enzyme inhibition showed 4a and 5 to be a non-competitive-type and mixed-type inhibitors, respectively. |
format |
article |
author |
Nguyen-Kim-Tuyen Pham Nguyen-Minh-An Tran Huy Truong Nguyen Duc-Dung Pham Thi-Quynh-Trang Nguyen Thi-Hong-Anh Nguyen Huu-Tri Nguyen Thanh-Hung Do Ngoc-Hong Nguyen Thuc-Huy Duong |
author_facet |
Nguyen-Kim-Tuyen Pham Nguyen-Minh-An Tran Huy Truong Nguyen Duc-Dung Pham Thi-Quynh-Trang Nguyen Thi-Hong-Anh Nguyen Huu-Tri Nguyen Thanh-Hung Do Ngoc-Hong Nguyen Thuc-Huy Duong |
author_sort |
Nguyen-Kim-Tuyen Pham |
title |
Design, modification, and bio-evaluation of salazinic acid derivatives |
title_short |
Design, modification, and bio-evaluation of salazinic acid derivatives |
title_full |
Design, modification, and bio-evaluation of salazinic acid derivatives |
title_fullStr |
Design, modification, and bio-evaluation of salazinic acid derivatives |
title_full_unstemmed |
Design, modification, and bio-evaluation of salazinic acid derivatives |
title_sort |
design, modification, and bio-evaluation of salazinic acid derivatives |
publisher |
Elsevier |
publishDate |
2022 |
url |
https://doaj.org/article/fb74b27e54f54a419bbf36b29bbda4e8 |
work_keys_str_mv |
AT nguyenkimtuyenpham designmodificationandbioevaluationofsalazinicacidderivatives AT nguyenminhantran designmodificationandbioevaluationofsalazinicacidderivatives AT huytruongnguyen designmodificationandbioevaluationofsalazinicacidderivatives AT ducdungpham designmodificationandbioevaluationofsalazinicacidderivatives AT thiquynhtrangnguyen designmodificationandbioevaluationofsalazinicacidderivatives AT thihonganhnguyen designmodificationandbioevaluationofsalazinicacidderivatives AT huutringuyen designmodificationandbioevaluationofsalazinicacidderivatives AT thanhhungdo designmodificationandbioevaluationofsalazinicacidderivatives AT ngochongnguyen designmodificationandbioevaluationofsalazinicacidderivatives AT thuchuyduong designmodificationandbioevaluationofsalazinicacidderivatives |
_version_ |
1718409942590816256 |